Show
Sort by
-
Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer
-
Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures
-
- Journal Article
- A1
- open access
Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium
-
- Journal Article
- A1
- open access
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine
-
Fluorine MR imaging probes dynamic migratory profiles of perfluorocarbon-loaded dendritic cells after streptozotocin-induced inflammation
-
- Journal Article
- A1
- open access
Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes
-
- Journal Article
- A1
- open access
The dawn of mRNA vaccines : the COVID-19 case
-
- Journal Article
- A1
- open access
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across
-
- Journal Article
- A1
- open access
Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation
-
- Journal Article
- A1
- open access
Longitudinal in vivo assessment of host-microbe interactions in a murine model of pulmonary aspergillosis
-
- Journal Article
- A1
- open access
Broadening the message : a nanovaccine co-loaded with messenger RNA and α-GalCer induces antitumor immunity through conventional and natural killer T cells
-
Challenges for labeling and longitudinal tracking of adoptively transferred autoreactive T lymphocytes in an experimental type-1 diabetes model
-
- Journal Article
- A1
- open access
Three decades of messenger RNA vaccine development
-
Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy
-
Co-delivery of nucleoside-modified mRNA and immunomodulators for cancer immunotherapy: restoring the immunogenicity of immunosilent mRNA
-
mRNA-based nanoparticles for therapeutic cancer vaccination
-
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy : restoring the immunogenicity of immunosilent mRNA
-
Immunogenic mRNA nanoparticles for dendritic cell-based cancer vaccination
-
Evaluation of mRNA lipoplexes for single-step antigen loading and maturation of dendritic cells in cancer immunotherapy
-
- Journal Article
- A1
- open access
Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro